Sodium Acetate Trihydrate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09395 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | congenital prothrombin deficiency | KG + DL |
| 2 | epiglottitis | KG + DL |
| 3 | urinary tract infection (disease) | KG + DL |
| 4 | sclerosing cholangitis | KG + DL |
| 5 | Ureaplasma urethritis | KG + DL |
| 6 | gonococcal urethritis | KG + DL |
| 7 | dyspepsia | KG + DL |
| 8 | uterine inflammatory disease | KG + DL |
| 9 | gastroparesis (disease) | KG + DL |
| 10 | xanthogranulomatous pyelonephritis | KG + DL |
| 11 | IgG4-related pachymeningitis | KG + DL |
| 12 | eosinophilic angiocentric fibrosis | KG + DL |
| 13 | IgG4-related mediastinitis | KG + DL |
| 14 | IgG4-related aortitis | KG + DL |
| 15 | IgG4-related mesenteritis | KG + DL |
| 16 | laryngitis | KG + DL |
| 17 | IgG4-related retroperitoneal fibrosis | KG + DL |
| 18 | myopathic intestinal pseudoobstruction | KG + DL |
| 19 | unclassified intestinal pseudoobstruction | KG + DL |
| 20 | neuronal intestinal dysplasia, type B | KG + DL |
| 21 | IgG4-related hepatopathy | KG + DL |
| 22 | congestive heart failure | KG + DL |
| 23 | intestinal obstruction | KG + DL |
| 24 | acute pulmonary heart disease | KG + DL |
| 25 | vitamin deficiency disorder | KG + DL |
| 26 | stomach disease | KG + DL |
| 27 | toxocariasis | KG + DL |
| 28 | non-syndromic esophageal malformation | KG + DL |
| 29 | type I complement component 8 deficiency | KG + DL |
| 30 | autosomal recessive hydrocephalus due to congenital stenosis of aqueduct of Sylvius | KG + DL |
| 31 | Alstrom syndrome | KG + DL |
| 32 | renal tubular acidosis | KG + DL |
| 33 | HELIX syndrome | KG + DL |
| 34 | Senior-Loken syndrome | KG + DL |
| 35 | primary hereditary glaucoma | KG + DL |
| 36 | bone Paget disease | KG + DL |
| 37 | esophageal disease | KG + DL |
| 38 | primary aldosteronism | KG + DL |
| 39 | autosomal recessive Ehlers-Danlos syndrome, vascular type | KG + DL |
| 40 | CoQ-responsive OXPHOS deficiency | KG + DL |
| 41 | autosomal recessive extra-oral halitosis | KG + DL |
| 42 | open-angle glaucoma | KG + DL |
| 43 | suppurative cholangitis | KG + DL |
| 44 | urogenital tuberculosis | KG + DL |
| 45 | pyridoxine deficiency anemia | KG + DL |
| 46 | autosomal recessive humeroradial synostosis | KG + DL |
| 47 | hyperphenylalaninemia due to tetrahydrobiopterin deficiency | KG + DL |
| 48 | fibular hypoplasia and complex brachydactyly | KG + DL |
| 49 | autosomal recessive axonal hereditary motor and sensory neuropathy | KG + DL |
| 50 | acrorenal syndrome, autosomal recessive | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.